Charles Craig

Minority HIV-1 Drug Resistance Mutations Are Present in Antiretroviral Treatment–Naïve Populations and Associate with Reduced Treatment Efficacy

Jeffrey A. Johnson, LI Jin-fen, Xierong Wei et al. · PLoS Medicine · 2008 · 372 citations · Full text

Abacavir Once or Twice Daily Combined With Once-Daily Lamivudine and Efavirenz for the Treatment of Antiretroviral-Naive HIV-Infected Adults

Graeme Moyle, Edwin DeJesus, Pedro Cahn et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2005 · 118 citations

Once-daily Use, Once-daily Lamivudine, Treatment And Prevention +12

Safety, adherence, and HIV-1 seroconversion among women using the dapivirine vaginal ring (DREAM): an open-label, extension study

Annaléne Nel, Neliëtte van Niekerk, Ben Van Baelen et al. · The Lancet HIV · 2021 · 95 citations · Full text

Identification of Biased Amino Acid Substitution Patterns in Human Immunodeficiency Virus Type 1 Isolates from Patients Treated with Protease Inhibitors

Robert W. Shafer, Phillip J. Hsu, Amy K. Patick et al. · Journal of Virology · 1999 · 72 citations · Full text

The Innate Immune Response, Clinical Outcomes, and Ex Vivo HCV Antiviral Efficacy of a TLR7 Agonist (PF-4878691)

Mark Fidock, B E Souberbielle, Carl Laxton et al. · Clinical Pharmacology & Therapeutics · 2011 · 70 citations